Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedMay 22, 2026
DataAggregated Company Financials
Companies6
- 7D2.4%
- 3M-9.8%
- 1Y-37.6%
- YTD-9.6%
The Pharma industry is up 2.4% in the last week, with InterCure up 3.9%. In the same time, Blue Wave Water Capital was down 23%. In contrast, the industry has lost 38% in the last 12 months.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 22 May 2026 | ₪415.0m | ₪728.3m | -₪132,839,768.40 | 54.6x | -3.1x | 0.6x |
| Sun, 19 Apr 2026 | ₪415.7m | ₪701.3m | -₪173,815,841.00 | 57.4x | -2.4x | 0.6x |
| Tue, 17 Mar 2026 | ₪440.1m | ₪706.6m | -₪160,960,584.00 | 6.9x | -2.7x | 0.6x |
| Thu, 12 Feb 2026 | ₪461.3m | ₪706.6m | -₪87,994,948.50 | 6.5x | -5.2x | 0.7x |
| Sat, 10 Jan 2026 | ₪462.7m | ₪706.6m | -₪88,249,826.90 | 6.2x | -5.2x | 0.7x |
| Mon, 08 Dec 2025 | ₪528.3m | ₪706.6m | -₪93,424,338.80 | 6.1x | -5.7x | 0.7x |
| Wed, 05 Nov 2025 | ₪579.7m | ₪720.3m | -₪92,656,364.30 | 6.9x | -6.3x | 0.8x |
| Fri, 03 Oct 2025 | ₪575.8m | ₪716.6m | -₪84,345,198.60 | 6.8x | -6.8x | 0.8x |
| Sun, 31 Aug 2025 | ₪574.4m | ₪716.7m | -₪66,944,779.10 | 29.1x | -8.6x | 0.8x |
| Tue, 29 Jul 2025 | ₪555.0m | ₪716.7m | -₪71,573,436.00 | 28.7x | -7.8x | 0.8x |
| Thu, 26 Jun 2025 | ₪578.5m | ₪716.7m | -₪71,767,234.30 | 31.1x | -8.1x | 0.8x |
| Sat, 24 May 2025 | ₪591.7m | ₪732.8m | -₪70,321,848.30 | 15.9x | -8.4x | 0.8x |
| Mon, 21 Apr 2025 | ₪566.1m | ₪766.6m | -₪80,722,392.00 | 14.4x | -7x | 0.7x |
| Wed, 19 Mar 2025 | ₪647.9m | ₪828.6m | -₪165,150,452.00 | 20.4x | -3.9x | 0.8x |
| Fri, 14 Feb 2025 | ₪667.2m | ₪828.6m | -₪180,226,360.40 | 22.1x | -3.7x | 0.8x |
| Sun, 12 Jan 2025 | ₪674.8m | ₪828.6m | -₪181,615,994.00 | 20.5x | -3.7x | 0.8x |
| Tue, 10 Dec 2024 | ₪611.9m | ₪828.6m | -₪180,164,573.00 | 20.6x | -3.4x | 0.7x |
| Thu, 07 Nov 2024 | ₪644.7m | ₪816.0m | -₪200,520,650.20 | 23x | -3.2x | 0.8x |
| Sat, 05 Oct 2024 | ₪681.8m | ₪808.7m | -₪206,621,677.40 | 24.1x | -3.3x | 0.8x |
| Mon, 02 Sep 2024 | ₪699.9m | ₪809.9m | -₪242,288,350.10 | 24.2x | -2.9x | 0.9x |
| Wed, 31 Jul 2024 | ₪692.3m | ₪901.7m | -₪263,134,640.80 | n/a | -2.6x | 0.8x |
| Fri, 28 Jun 2024 | ₪648.6m | ₪901.7m | -₪258,196,202.00 | n/a | -2.5x | 0.7x |
| Sun, 26 May 2024 | ₪835.7m | ₪886.2m | -₪255,618,318.80 | n/a | -3.3x | 0.9x |
| Tue, 23 Apr 2024 | ₪735.2m | ₪956.4m | -₪180,775,200.00 | 20.6x | -4.1x | 0.8x |
| Thu, 21 Mar 2024 | ₪704.2m | ₪972.3m | -₪208,025,468.00 | 17.2x | -3.4x | 0.7x |
| Sat, 17 Feb 2024 | ₪627.9m | ₪972.3m | -₪211,551,048.10 | 13x | -3x | 0.6x |
| Mon, 15 Jan 2024 | ₪583.2m | ₪972.3m | -₪214,257,644.00 | 11.6x | -2.7x | 0.6x |
| Wed, 13 Dec 2023 | ₪604.0m | ₪972.3m | -₪213,657,348.00 | 10.5x | -2.8x | 0.6x |
| Fri, 10 Nov 2023 | ₪578.1m | ₪958.8m | -₪210,431,053.00 | 9.3x | -2.7x | 0.6x |
| Sun, 08 Oct 2023 | ₪678.4m | ₪958.8m | -₪210,495,691.00 | 13.1x | -3.2x | 0.7x |
| Tue, 05 Sep 2023 | ₪651.2m | ₪956.9m | -₪206,570,141.00 | 12.9x | -3.2x | 0.7x |
| Thu, 03 Aug 2023 | ₪635.7m | ₪918.8m | -₪126,003,802.00 | 8.3x | -5x | 0.7x |
| Sat, 01 Jul 2023 | ₪683.3m | ₪918.8m | -₪126,652,494.00 | 8.9x | -5.4x | 0.7x |
| Mon, 29 May 2023 | ₪817.3m | ₪906.2m | -₪127,624,897.00 | 11.7x | -6.4x | 0.9x |
Price to Earnings Ratio
-6.4x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.74x.
Past Earnings Growth
- Losses for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have declined 7.0% per year.
- This means that the cost of doing business could be reducing since sales have declined but losses haven't fallen much further.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 0.60% | |
| Healthcare | -1.50% | |
| Pharma | 2.38% | |
| Pharma | 2.38% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| INCR InterCure | ₪2.52 | 3.9% +₪5.1m | -55.4% | PS0.5x | |
| SEMG Seach Medical Group | ₪2.59 | 5.2% +₪4.1m | -3.4% | PE54.6x | |
| REKA Rekah Pharmaceutical Industry | ₪11.21 | 1.7% +₪2.2m | -18.6% | PS0.4x | |
| YBRD Y.B Urban Renewal - Residential Development | ₪7.71 | 4.7% +₪1.6m | 54.1% | PB4.2x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪16.25 | 0.9% +₪127.4k | -57.2% | PS1.5x |